Clinical Trial Update: An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening [Phase 4]

View source ↗

Summary

A Phase 4 open-label, investigator-initiated study assessing the duration and efficacy of Jornay PM (methylphenidate extended-release) on adult ADHD symptoms, e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Jornay PM (methylphenidate hydrochloride extended-release)

Snippet

Sponsor: NYU Langone Health | Conditions: Attention-deficit/Hyperactivity Disorder | Phase 4 | Status: RECRUITING